Comments
Cadila Pharmaceuticals Ltd (Zydus Cadila) on Saturday said it has received an approval from the United States Food and Drug Administration (USFDA) for Irbesartan tablets, used in the treatment of hypertension.
The approval has been given for USP 75 mg, 150 mg and 300 mg, according to a company statement here.
The estimated sales in 2011 as per NDC for Irbesartan Tablets were $489 million.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.